Onivyde 43 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DR26FCRH7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,719
Award facts
- Contract value 100% obligated
- $11,719.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,719.38 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of ONIVYDE 43 mg/10 ml vials. This firm fixed-price delivery order was issued on November 12, 2025, with an ultimate completion date of December 4, 2025, and carries no set-aside designation. The award represents procurement activity under DMS Pharmaceutical Group's recently established Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical supply support to Department of Defense military healthcare facilities worldwide.
DMS Pharmaceutical Group's selection as a prime vendor contractor under PPV-G GEN V, with an IDC ceiling value of $499,999,999 and completion date of December 31, 2036, positions the company as a critical supplier within the federal military medical supply chain. The company's extensive product portfolio includes oncology treatments, immunosuppressants, biologics, vaccines, and specialty pharmaceuticals, enabling it to fulfill diverse medical requirements across military healthcare operations globally. This delivery order for ONIVYDE, an oncology pharmaceutical, exemplifies the specialized pharmaceutical procurement conducted through the prime vendor program to support recurring medical supply needs of the Department of Defense.
Quick answers
Who was awarded contract SPE2DR26FCRH7?
SPE2DR26FCRH7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DR26FCRH7 worth?
The government has obligated $11,719 on SPE2DR26FCRH7.
Is contract SPE2DR26FCRH7 an order under another contract?
Yes. SPE2DR26FCRH7 is a delivery order under SPE2DR25D9168, an indefinite delivery contract.
Was contract SPE2DR26FCRH7 competed?
The extent of competition for SPE2DR26FCRH7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award